Physiological functions and pharmacological and toxicological effects of p-octopamine
p-Octopamine occurs naturally in plants, invertebrates and animals with diverse functions and effects. This review summarizes the chemistry, metabolism, receptor binding characteristics, known physiological functions, and pharmacological and toxicological effects of p-octopamine. Databases used included PubMed and Google Scholar Advanced. p-Octopamine binds to neuroreceptors in insects that are not present in humans, while exhibiting poor binding to α-1, α-2, β-1, and β-2 adrenergic receptors in mammalian systems. p-Octopamine modestly binds to β-3 adrenergic receptors and may therefore promote lipolysis and weight loss. p-Octopamine is produced in brain and nerve tissues of mammals and is present and can be measured in the blood of normal human subjects. p-Octopamine is considered to be a CNS stimulant in spite of the fact that it binds poorly to adrenergic receptors. Variations occur in blood levels in association with neurological and hepatic diseases. Its precise role in normal neurophysiology is unclear. No human studies have been reported that demonstrate adverse cardiovascular effects following oral administration. No human studies have examined the effects of p-octopamine on athletic performance or weight loss and weight management. A need exists for both animal and human safety and efficacy studies involving oral administration of p-octopamine.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2015 |
|---|---|
| Erschienen: |
2015 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:38 |
|---|---|
| Enthalten in: |
Drug and chemical toxicology - 38(2015), 1 vom: 23. Jan., Seite 106-12 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Stohs, Sidney J [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
14O50WS8JD |
|---|
| Anmerkungen: |
Date Completed 15.09.2015 Date Revised 16.01.2019 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.3109/01480545.2014.900069 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM236624709 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM236624709 | ||
| 003 | DE-627 | ||
| 005 | 20231224105943.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231224s2015 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.3109/01480545.2014.900069 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n0788.xml |
| 035 | |a (DE-627)NLM236624709 | ||
| 035 | |a (NLM)24654910 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Stohs, Sidney J |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Physiological functions and pharmacological and toxicological effects of p-octopamine |
| 264 | 1 | |c 2015 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 15.09.2015 | ||
| 500 | |a Date Revised 16.01.2019 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a p-Octopamine occurs naturally in plants, invertebrates and animals with diverse functions and effects. This review summarizes the chemistry, metabolism, receptor binding characteristics, known physiological functions, and pharmacological and toxicological effects of p-octopamine. Databases used included PubMed and Google Scholar Advanced. p-Octopamine binds to neuroreceptors in insects that are not present in humans, while exhibiting poor binding to α-1, α-2, β-1, and β-2 adrenergic receptors in mammalian systems. p-Octopamine modestly binds to β-3 adrenergic receptors and may therefore promote lipolysis and weight loss. p-Octopamine is produced in brain and nerve tissues of mammals and is present and can be measured in the blood of normal human subjects. p-Octopamine is considered to be a CNS stimulant in spite of the fact that it binds poorly to adrenergic receptors. Variations occur in blood levels in association with neurological and hepatic diseases. Its precise role in normal neurophysiology is unclear. No human studies have been reported that demonstrate adverse cardiovascular effects following oral administration. No human studies have examined the effects of p-octopamine on athletic performance or weight loss and weight management. A need exists for both animal and human safety and efficacy studies involving oral administration of p-octopamine | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a Adrenergic receptors | |
| 650 | 4 | |a biomarker | |
| 650 | 4 | |a metabolism | |
| 650 | 4 | |a norsynephrine | |
| 650 | 4 | |a prohibited substance | |
| 650 | 4 | |a trace amines | |
| 650 | 4 | |a weight loss | |
| 650 | 7 | |a Receptors, Biogenic Amine |2 NLM | |
| 650 | 7 | |a norsynephrine receptor |2 NLM | |
| 650 | 7 | |a Octopamine |2 NLM | |
| 650 | 7 | |a 14O50WS8JD |2 NLM | |
| 773 | 0 | 8 | |i Enthalten in |t Drug and chemical toxicology |d 1984 |g 38(2015), 1 vom: 23. Jan., Seite 106-12 |w (DE-627)NLM000913685 |x 1525-6014 |7 nnns |
| 773 | 1 | 8 | |g volume:38 |g year:2015 |g number:1 |g day:23 |g month:01 |g pages:106-12 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.3109/01480545.2014.900069 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 38 |j 2015 |e 1 |b 23 |c 01 |h 106-12 | ||